Fluence Corporation (EMFGF) Fair Value & Analysis
Industrials · US · Market cap $63.0M
Fair value as of: Jun 26, 2026
Analysis
Fluence Corporation (EMFGF) currently trades at $0.0551, while our model-based Fair Value estimate is $0.1349 — implying the stock looks roughly 144.9% undervalued today. We read business quality at 90/100 (high quality), in the Industrials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
About the company
Fluence Corporation Limited, together with its subsidiaries, provides smart water and wastewater treatment solutions for the municipal, commercial, and industrial markets worldwide. It offers water treatment solutions, such as reverse-osmosis desalination, clarification, multimedia filtration, methane removal, arsenic removal, denitrification, UV disinfection, softening, mollusk removal, coagulation and flocculation, flotation, activated carbon filtration, biological filtration, contaminants removal, ultrafiltration, remineralization, and ozonation. The company also provides NIROBOX Smart Packaged Water Solutions for seawater and brackish water desalination, as well as freshwater treatment; NIROFLEX, pre-engineered pretreatment and reverse osmosis building blocks for cost-effective seawater desalination systems; and desalination for drinking water, industrial process water desalination, seawater reverse osmosis, and brine management. In addition, it offers wastewater treatment solut…
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Fluence Corporation (EMFGF) undervalued?
What is the fair value of EMFGF?
What is the quality score of EMFGF?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.